Evidence map›Paper›PMID 35710559›Full record

ArticleScientific reports2022

A spatiotemporal multi-scale computational model for FDG PET imaging at different stages of tumor growth and angiogenesis.

Farshad Moradi Kashkooli, Mohammad Amin Abazari, M Soltani, Mehran Akbarpour Ghazani, Arman Rahmim

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. A microscopic computational simulation of [Physics in medicine and biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Cancers · 2026
    Article
  6. Article
  7. Non-[Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Clinical significance ofEuropean journal of medical research · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Farshad Moradi Kashkooli *Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Mohammad Amin Abazari *Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
M SoltaniDepartment of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran. msoltani@uwaterloo.ca.
Mehran Akbarpour GhazaniDepartment of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran.
Arman RahmimDepartment of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
K.N.Toosi University of Technology · IRUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A deeper understanding of the tumor microenvironment (TME) and its role in metabolic activity at different stages of vascularized tumors can provide useful insights into cancer progression and better support clinical assessments. In this study, a robust and comprehensive multi-scale computational model for spatiotemporal transport of F-18 fluorodeoxyglucose (FDG) is developed to incorporate important aspects of the TME, spanning subcellular-, cellular-, and tissue-level scales. Our mathematical model includes biophysiological details, such as radiopharmaceutical transport within interstitial space via convection and diffusion mechanisms, radiopharmaceutical exchange between intracellular and extracellular matrices by glucose transporters, cellular uptake of radiopharmaceutical, as well as its intracellular phosphorylation by the enzyme. Further, to examine the effects of tumor size by varying microvascular densities (MVDs) on FDG dynamics, four different capillary networks are generated by angiogenesis modeling. Results demonstrate that as tumor grows, its MVD increases, and hence, the spatiotemporal distribution of total FDG uptake by tumor tissue changes towards a more homogenous distribution. In addition, spatiotemporal distributions in tumor with lower MVD have relatively smaller magnitudes, due to the lower diffusion rate of FDG as well as lower local intravenous FDG release. Since mean standardized uptake value (SUV

Indexed as

Fluorodeoxyglucose F18NeoplasmsHumansNeovascularization, PathologicPositron-Emission TomographyRadiopharmaceuticalsTumor MicroenvironmentFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID35710559
PMCPMC9203789
OpenAlexW4283015563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.